India-EU Free Trade Agreement Opens USD 572 Billion Pharma, MedTech Market for Indian Industry
The FTA unlocks access to the USD 572.3 billion EU pharmaceuticals & medical devices market giving impetus to the Indian Pharmaceuticals sector.
New Delhi: India and the European Union (EU) announced the conclusion of negotiations for a Free Trade Agreement (FTA), an important milestone in one of India's most strategic economic partnerships. Designed as a modern, rules-based trade partnership, the FTA responds to contemporary global challenges while enabling deeper market integration between the world's 4th and 2nd largest economies.
The FTA unlocks access to the $572.3 billion EU pharmaceuticals & medical devices market giving impetus to the Indian Pharmaceuticals sector. This would enable Pharma industries to scale, generate employment, and reinforce India’s positioning as a reliable partner in the pharmaceuticals sector underlining its growing stature as the pharmacy of the world .It is expected to expand skilled jobs, industrial employment, stronger MSME participation and strengthen global supply chain integration.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.